Agile Therapeutics, Inc. Derivative Liability, Noncurrent
Agile Therapeutics, Inc. had Derivative Liability, Noncurrent of $10.65 million as of 2024-06-30, per its 10-Q filed 2024-08-12.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DerivativeLiabilitiesNoncurrent · last filed 2024-08-12
- 2024-06-30: Derivative Liability, Noncurrent $10.65M.
- 2024-03-31: Derivative Liability, Noncurrent $1.49M.
- 2023-12-31: Derivative Liability, Noncurrent $5.70M.
- 2023-09-30: Derivative Liability, Noncurrent $5.57M.
| Period end | Derivative Liability, Noncurrent |
|---|---|
| 2024-06-30 | $10.65M 10-Q · filed 2024-08-12 |
| 2024-03-31 | $1.49M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $5.70M 10-Q · filed 2024-08-12 |
| 2023-09-30 | $5.57M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $9.10M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $4.25M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $5.93M 10-K · filed 2024-03-28 |
| 2022-09-30 | $9.29M 10-K · filed 2023-03-23 |
| 2022-06-30 | $1.05M 10-K · filed 2023-03-23 |
| 2022-03-31 | $8.10M 10-K · filed 2023-03-23 |
| 2021-12-31 | $5.36M 10-K · filed 2023-03-23 |